These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22390562)

  • 1. Targeting adenosine receptors in the development of cardiovascular therapeutics.
    Riksen NP; Rongen GA
    Expert Rev Clin Pharmacol; 2012 Mar; 5(2):199-218. PubMed ID: 22390562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.
    Shryock JC; Belardinelli L
    Am J Cardiol; 1997 Jun; 79(12A):2-10. PubMed ID: 9223356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosinergic cardioprotection: multiple receptors, multiple pathways.
    Peart JN; Headrick JP
    Pharmacol Ther; 2007 May; 114(2):208-21. PubMed ID: 17408751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote postconditioning may attenuate ischaemia-reperfusion injury in the murine hindlimb through adenosine receptor activation.
    Tsubota H; Marui A; Esaki J; Bir SC; Ikeda T; Sakata R
    Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):804-9. PubMed ID: 20869891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiovascular effects of adenosine: clinical use and nursing implications.
    Teplitz L
    Prog Cardiovasc Nurs; 1993; 8(2):20-8. PubMed ID: 7937680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine attenuates oxidant injury in human proximal tubular cells via A(1) and A(2a) adenosine receptors.
    Lee HT; Emala CW
    Am J Physiol Renal Physiol; 2002 May; 282(5):F844-52. PubMed ID: 11934694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against Storage/Reperfusion injury in rat livers.
    Arai M; Thurman RG; Lemasters JJ
    Hepatology; 2000 Aug; 32(2):297-302. PubMed ID: 10915736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of glial cell functions by adenosine receptors.
    Daré E; Schulte G; Karovic O; Hammarberg C; Fredholm BB
    Physiol Behav; 2007 Sep; 92(1-2):15-20. PubMed ID: 17574632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecto-5'-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo.
    Huang DY; Vallon V; Zimmermann H; Koszalka P; Schrader J; Osswald H
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F282-8. PubMed ID: 16525161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.
    Harada N; Okajima K; Murakami K; Usune S; Sato C; Ohshima K; Katsuragi T
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1034-42. PubMed ID: 10945856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-inflammatory potential of adenosine in ischemia-reperfusion injury: established and putative beneficial actions of a retaliatory metabolite.
    Bouma MG; van den Wildenberg FA; Buurman WA
    Shock; 1997 Nov; 8(5):313-20. PubMed ID: 9361340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injury.
    Di Paola R; Melani A; Esposito E; Mazzon E; Paterniti I; Bramanti P; Pedata F; Cuzzocrea S
    Shock; 2010 May; 33(5):541-51. PubMed ID: 19924030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoA inhibition is a key step in pituicyte stellation induced by A(1)-type adenosine receptor activation.
    Rosso L; Peteri-Brunbäck B; Vouret-Craviari V; Deroanne C; Troadec JD; Thirion S; Van Obberghen-Schilling E; Mienville JM
    Glia; 2002 Jun; 38(4):351-62. PubMed ID: 12007147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine's effect on myocardial functional recovery: substrate or signal?
    Bolling SF; Childs KF; Ning XH
    J Surg Res; 1994 Nov; 57(5):591-5. PubMed ID: 7967597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel.
    Zhao TC; Kukreja RC
    J Mol Cell Cardiol; 2002 Mar; 34(3):263-77. PubMed ID: 11945020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ectoenzymes on p2 and p1 receptor signaling.
    Kukulski F; Lévesque SA; Sévigny J
    Adv Pharmacol; 2011; 61():263-99. PubMed ID: 21586362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Adenosine Receptor Ligands: Potential Role in the Treatment of Cardiovascular Diseases.
    Geldenhuys WJ; Hanif A; Yun J; Nayeem MA
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28587166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMP-activated protein kinase as a target for preconditioning in transplantation medicine.
    Bouma HR; Ketelaar ME; Yard BA; Ploeg RJ; Henning RH
    Transplantation; 2010 Aug; 90(4):353-8. PubMed ID: 20571465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine is a negative regulator of NF-kappaB and MAPK signaling in human intestinal epithelial cells.
    Jijon HB; Walker J; Hoentjen F; Diaz H; Ewaschuk J; Jobin C; Madsen KL
    Cell Immunol; 2005 Oct; 237(2):86-95. PubMed ID: 16413516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.